Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/18/25 16:49 | 2/14/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Greenstreet Yvonne | MA | DO | CEO | 2 | S | -1,619 | 251.77 | 0 | -6 | 82 | D | |||||||||||||||
2/18/25 16:47 | 2/14/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Poulton Jeffrey V. | MA | O | EVP,CFO | 2 | S | -669 | 252.51 | 0 | -3 | 33 | D | |||||||||||||||
2/18/25 16:47 | 2/14/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Fitzgerald Kevin Joseph | MA | O | CSO,EVP, | 2 | S.m | -1,286 | 252.09 | 0 | -5 | 13 | D | |||||||||||||||
2/18/25 16:47 | 2/14/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Garg Pushkal | MA | O | CMO,EVP | 5 | S.dm | -20,986 | 194.30 | 0 | -108 | 18 | D | |||||||||||||||
1/24/25 16:10 | 1/23/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Sharp Phillip A | MA | D | 2 | M.d | 4,570 | 203.11 | 0 | 23 | 9 | 267 | D | |||||||||||||||
1/24/25 16:10 | 1/23/25 | ALNY | Health | Drug | Pharmaceutical Preparations | Sharp Phillip A | MA | D | 2 | S.d | -4,570 | 203.11 | 0 | -23 | 267 | D | ||||||||||||||||
11/27/24 17:21 | 11/26/24 | ALNY | Health | Drug | Pharmaceutical Preparations | Tanguler Tolga | MA | O | EVP,Chie | 1 | S | -369 | 250.98 | 0 | -1 | 13 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |